Stay updated on BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities
Sign up to get notified when there's something new on the BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities page.

Latest updates to the BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities page
- Check3 days agoChange Detected- Revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedAdded Revision: v3.4.2 to the page and removed a government funding/operating status notice; these are minor maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check38 days agoChange DetectedA site-wide notice about a lapse in government funding was added, indicating that information on the site may not be up to date. The revision version was updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

- Check45 days agoChange DetectedThe page now shows a glossary and includes the 'Last Update Submitted that Met QC Criteria' label and a new 'Revision: v3.4.0' tag, while the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' references were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check60 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this update does not modify any study details, eligibility criteria, or results.SummaryDifference0.0%

- Check81 days agoChange DetectedLocations section expanded to include multiple study sites across the US, Australia, and Korea (e.g., Massachusetts, Texas, New South Wales, Queensland, South Australia, Victoria, Western Australia, Kyeonggi-do). The revision tag updated from v3.3.2 to v3.3.3.SummaryDifference0.8%

Stay in the know with updates to BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities
Enter your email address, and we'll notify you when there's something new on the BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities page.